![Andrea James](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 1 M $ al 31/05/2026
Andrea James is Chief Financial Officer at Insight Molecular Diagnostics, Inc. since 2024.
Formerly, Ms. James was Vice President at Colliers Securities LLC and Chief Communications Officer at Axon Enterprise, Inc. from 2022 to 2023.
Ms. James completed undergraduate studies at American University and graduate studies at Northwestern University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/04/2026 | 206.060 ( 0,72 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Director Financiero/CFO | 17/06/2024 |
| Empresas | Cargo | Fin |
|---|---|---|
| AXON ENTERPRISE, INC. | Contacto de Relaciones con Inversores | 27/09/2022 |
Colliers Securities LLC
 Colliers Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Axon Enterprise, Inc.
 Axon Enterprise, Inc. Aerospace & DefenseElectronic Technology Develops and manufactures advanced conducted electrical weapons and software | Electronic Technology |
Colliers Securities LLC
Colliers Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
American University
 American University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OncoCyte Corp.
 OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
